Advertisement

TRAF1 and Its Biological Functions

  • Soo Young Lee
  • Yongwon Choi
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 597)

Abstract

Tumor necrosis factor (TNF) receptor-associated factor (TRAF)1 was originally identified based on its ability to interact with the cytosolic domain of TNF receptor type 2 (TNFR2). TRAF1 is unique among TRAF proteins in that it lacks RING domain found in the N-terminal regions of other TRAFs. TRAF1 can associate with multiple TNFR family members and can also bind several protein kinases and adaptor proteins suggesting that this protein likely possesses multiple functions in cytokine signaling networks. Although our understanding of TRAF1 functions and the underlying mechanisms at molecular and cellular levels has been advanced in recent years, much still needs to be learned before we have a full grasp of TRAF1 biology.

Keywords

Tumor Necrosis Factor Receptor Tumor Necrosis Factor Receptor Superfamily Tumor Necrosis Factor Signaling Tumor Necrosis Factor Ligand Tumor Necrosis Factor Receptor Type 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Baker SJ, Reddy EP. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 1996; 12:1–9.PubMedGoogle Scholar
  2. 2.
    Arch RH, Gedrich RW, Thompson CB. Tumor necrosis factor receptor-associated factors (TRAFs) — A family of adapter ptoteins that regulates life and death. Genes Dev 1998; 12:2821–2830.PubMedGoogle Scholar
  3. 3.
    Kaufman D, Choi Y. Signaling by tumor necrosis factor receptors: Pathways, paradigms and targets for therapeutic modulation. Intern Rev Immunol 1999; 18:405–427.Google Scholar
  4. 4.
    Inoue J, Ishida T, Tsukamoto N et al. Tumor necrosis factor receptor-associated factor (TRAF) family: Adapter proteins that mediate cytokine signaling. Exp Cell Res 2000; 254:14–24.PubMedCrossRefGoogle Scholar
  5. 5.
    Wajant H, Henkler F, Scheurich P. The TNF-receptor-associated factor family scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal 2001; 13:389–400.PubMedCrossRefGoogle Scholar
  6. 6.
    Chung JY, Park YC, Ye H et al. All TRAFs are not created equal: Common and distinct molecular mechanisms of TRAF-mediated signal transduction. J Cell Sci 2002; 115:679–688.PubMedGoogle Scholar
  7. 7.
    Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 2001; 104:487–501.PubMedCrossRefGoogle Scholar
  8. 8.
    Yeh WC, Shahinian A, Speiser D et al. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 1997; 7:715–725.PubMedCrossRefGoogle Scholar
  9. 9.
    Tada K, Okazaki T, Sakon S et al. Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-κB activation and protection from cell death. J Biol Chem 2001; 276:36530–36534.PubMedCrossRefGoogle Scholar
  10. 10.
    Lomaga MA, Yeh WC, Sarosi I et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 1999; 13:1015–1024.PubMedGoogle Scholar
  11. 11.
    Dempsey PW, Doyle SE, He JQ et al. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev 2003; 14:193–209.PubMedCrossRefGoogle Scholar
  12. 12.
    Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 2003; 10:45–65.PubMedCrossRefGoogle Scholar
  13. 13.
    Rothe M, Wong SC, Henzel WJ et al. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 1994; 78:681–692.PubMedCrossRefGoogle Scholar
  14. 14.
    Mosialos G, Birkenbach M, Yalamanchili R et al. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 1995; 80:389–399.PubMedCrossRefGoogle Scholar
  15. 15.
    Lee SY, Park CG, Choi Y. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J Exp Med 1996; 183:669–674.PubMedCrossRefGoogle Scholar
  16. 16.
    Hsu H, Shu HB, Pan MG et al. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996; 84:299–308.PubMedCrossRefGoogle Scholar
  17. 17.
    Natoli G, Costanzo A, Ianni A et al. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 1997; 275:200–203.PubMedCrossRefGoogle Scholar
  18. 18.
    Zapata JM, Krajewska M, Krajewski S et al. TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies. J Immunol 2000; 165:5084–5096.PubMedGoogle Scholar
  19. 19.
    Schwenzer R, Siemienski K, Liptay S et al. The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-κB and c-Jun N-terminal kinase. J Biol Chem 1999; 274:19368–19374.PubMedCrossRefGoogle Scholar
  20. 20.
    Durkop H, Foss HD, Demel G et al. Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkin’s disease and Epstein-Barr virus-transformed lymphoid cells. Blood 1999; 93:617–623.PubMedGoogle Scholar
  21. 21.
    Dunn IF, Geha RS, Tsitsikov EN. Structure of the murine TRAF1 gene. Mol Immunol 1999; 36:611–617.PubMedCrossRefGoogle Scholar
  22. 22.
    Wang X, Wang Q, Hu W et al. Regulation of phorbol ester-mediated TRAF1 induction in human colon cancer cells through a PKC/RAF/ERK/NF-κB-dependent pathway. Oncogene 2004; 23:1885–1195.PubMedCrossRefGoogle Scholar
  23. 23.
    Zapata JM, Reed JC. TRAF1: Lord without a RING. Sci STKE 2002; 21:PE27.Google Scholar
  24. 24.
    Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 1995; 81:495–504.PubMedCrossRefGoogle Scholar
  25. 25.
    Ye H, Park YC, Kreishman M et al. The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol Cell 1999; 4:321–330.PubMedCrossRefGoogle Scholar
  26. 26.
    Park YC, Burkitt V, Villa AR et al. Structural basis for self-association and receptor recognition of human TRAF2. Nature 1999; 398:533–538.PubMedCrossRefGoogle Scholar
  27. 27.
    Ye H, Arron JR, Lamothe B et al. Distinct molecular mechanism for initiating TRAF6 signalling. Nature 2002; 418:443–447.PubMedCrossRefGoogle Scholar
  28. 28.
    Gedrich RW, Gilfillan MC, Duckett CS et al. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. J Biol Chem 1996; 271:12852–12858.PubMedCrossRefGoogle Scholar
  29. 29.
    Lee SY, Lee SY, Kandala G et al. CD30/TNF receptor-associated factor interaction: NF-κB activation and binding specificity. Proc Natl Acad Sci USA 1996; 93:9699–9703.PubMedCrossRefGoogle Scholar
  30. 30.
    Duckett CS, Gedrich RW, Gilfillan MC et al. Induction of nuclear factor κB by the CD30 receptor is mediated by TRAF1 and TRAF2. Mol Cell Biol 1997; 17:1535–1542.PubMedGoogle Scholar
  31. 31.
    Carpentier I, Beyaert R. TRAF1 is a TNF inducible regulator of NF-κB activation. FEBS Lett 1999; 460:246–250.PubMedCrossRefGoogle Scholar
  32. 32.
    Arron JR, Pewzner-Jung Y, Walsh MC et al. Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling. J Exp Med 2002; 196:923–934.PubMedCrossRefGoogle Scholar
  33. 33.
    Fotin-Mleczek M, Henkler F, Hausser A et al. Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-κB activation. J Biol Chem 2004; 279:677–685.PubMedCrossRefGoogle Scholar
  34. 34.
    Chen G, Goeddel DV. TNF-R1 signaling: A beautiful pathway. Science 2002; 296:1634–1635.PubMedCrossRefGoogle Scholar
  35. 35.
    Karin M, Lin A. NF-κB at the crossroads of life and death. Nat Immunol 2002; 3:221–227.PubMedCrossRefGoogle Scholar
  36. 36.
    Shu HB, Takeuchi M, Goeddel DV. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc Natl Acad Sci USA 1996; 93:13973–13978.PubMedCrossRefGoogle Scholar
  37. 37.
    Wang CY, Mayo MW, Korneluk RG et al. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998; 281:1680–1683.PubMedCrossRefGoogle Scholar
  38. 38.
    Speiser DE, Lee SY, Wong B et al. A regulatory role for TRAF1 in antigen-induced apoptosis of T cells. J Exp Med 1997; 185:1777–1783.PubMedCrossRefGoogle Scholar
  39. 39.
    Irmler M, Steiner V, Ruegg C et al. Caspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosis. FEBS Lett 2000; 468:129–133.PubMedCrossRefGoogle Scholar
  40. 40.
    Jang HD, Chung YM, Baik JH et al. Caspase-cleaved TRAF1 negatively regulates the antiapoptotic signals of TRAF2 during TNF-induced cell death. Biochem Biophys Res Commun 2001; 281:499–505.PubMedCrossRefGoogle Scholar
  41. 41.
    Leo E, Deveraux QL, Buchholtz C et al. TRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-alpha-induced apoptosis. J Biol Chem 2001; 276:8087–8093.PubMedCrossRefGoogle Scholar
  42. 42.
    Henkler F, Baumann B, Fotin-Mleczek M et al. Caspase-mediated cleavage converts the tumor necrosis factor (TNF) receptor-associated factor (TRAF)-1 from a selective modulator of TNF receptor signaling to a general inhibitor of NF-κB activation. J Biol Chem 2003; 278:29216–29230.PubMedCrossRefGoogle Scholar
  43. 43.
    Tsitsikov EN, Laouini D, Dunn IF et al. TRAF1 is a negative regulator of TNF signaling: Enhanced TNF signaling in TRAF1-deficient mice. Immunity 2001; 15:647–657.PubMedCrossRefGoogle Scholar
  44. 44.
    Nakano H, Sakon S, Koseki H et al. Targeted disruption of Traf5 gene causes defects in CD40-and CD27-mediated lymphocyte activation. Proc Natl Acad Sci USA 1999; 96:9803–9808.PubMedCrossRefGoogle Scholar
  45. 45.
    Xu Y, Cheng G, Baltimore D. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity 1996; 5:407–415.PubMedCrossRefGoogle Scholar
  46. 46.
    Regnier CH, Masson R, Kedinger V et al. Impaired neural tube closure, axial skeleton malformations, and tracheal ring disruption in TRAF4-deficient mice. Proc Natl Acad Sci USA 2002; 99:5585–5590.PubMedCrossRefGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2007

Authors and Affiliations

  • Soo Young Lee
  • Yongwon Choi
    • 1
  1. 1.Department of Pathology and Laboratory Medicine, Abramson Family Cancer Research InstituteUniversity of Pennsylvania School of MedicinePhiladelphiaUSA

Personalised recommendations